scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1003823475 |
P356 | DOI | 10.1208/S12248-009-9094-3 |
P932 | PMC publication ID | 2664893 |
P698 | PubMed publication ID | 19291412 |
P5875 | ResearchGate publication ID | 24205706 |
P2093 | author name string | Wei Zhang | |
Subramaniam Ananthan | |||
Judith Varady Hobrath | |||
P2860 | cites work | High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor | Q24657484 |
Crystal structure of rhodopsin: A G protein-coupled receptor | Q27625972 | ||
Advances in Determination of a High-Resolution Three-Dimensional Structure of Rhodopsin, a Model of G-Protein-Coupled Receptors (GPCRs) | Q27632765 | ||
Crystal structure of the human beta2 adrenergic G-protein-coupled receptor | Q27648868 | ||
A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic Receptor | Q27650801 | ||
Crystal structure of the ligand-free G-protein-coupled receptor opsin | Q27650885 | ||
Structure of a beta1-adrenergic G-protein-coupled receptor | Q27651011 | ||
Crystal structure of opsin in its G-protein-interacting conformation | Q27652301 | ||
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function | Q28254935 | ||
A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist. | Q30357121 | ||
Structure-based virtual screening of chemical libraries for drug discovery | Q33242317 | ||
Virtual ligand screening: strategies, perspectives and limitations | Q33247681 | ||
Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors | Q33260986 | ||
GPCR structure-based virtual screening approach for CB2 antagonist search | Q33288322 | ||
Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening | Q33360557 | ||
Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening | Q34776186 | ||
I want a new drug: G-protein-coupled receptors in drug development | Q36483932 | ||
Discovery of novel agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening | Q37013424 | ||
A virtual screen for diverse ligands: discovery of selective G protein-coupled receptor antagonists | Q39999810 | ||
Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets? | Q44242205 | ||
Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds | Q46336635 | ||
Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor | Q46445968 | ||
Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols | Q46655989 | ||
Binding mode analysis and enrichment studies on homology models of the human histamine H4 receptor | Q46977726 | ||
Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. | Q51791975 | ||
Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring | Q53037530 | ||
Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery | Q80616052 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | G protein-coupled receptor | Q38173 |
protein structure | Q735188 | ||
virtual screening | Q4112105 | ||
P304 | page(s) | 178-185 | |
P577 | publication date | 2009-03-17 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | The AAPS Journal | Q10695361 |
P1476 | title | Recent advances in structure-based virtual screening of G-protein coupled receptors | |
P478 | volume | 11 |
Q36088280 | Differential Virtual Screening (DVS) with Active and Inactive Molecular Models for Finding and Profiling GPCR Modulators: Case of the CCK1 Receptor |
Q35840893 | How well do the substrates KISS the enzyme? Molecular docking program selection for feruloyl esterases. |
Q64092935 | ImmtorLig_DB: repertoire of virtually screened small molecules against immune receptors to bolster host immunity |
Q45943415 | Methods for Virtual Screening of GPCR Targets: Approaches and Challenges. |
Q41617618 | Monte Carlo loop refinement and virtual screening of the thyroid-stimulating hormone receptor transmembrane domain |
Q39152860 | Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors |
Q35962179 | Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics |
Q38028544 | Systems biology visualization tools for drug target discovery |
Q33640639 | Using ligand-based virtual screening to allosterically stabilize the activated state of a GPCR. |
Search more.